Hyperparathyroidism Which Developed after Resection of a Fibroblast Growth Factor 23-producing Tumor.
fibroblast growth factor 23-producing tumor
manifestation
primary hyperparathyroidism
Journal
Internal medicine (Tokyo, Japan)
ISSN: 1349-7235
Titre abrégé: Intern Med
Pays: Japan
ID NLM: 9204241
Informations de publication
Date de publication:
15 Oct 2020
15 Oct 2020
Historique:
pubmed:
10
7
2020
medline:
23
2
2021
entrez:
10
7
2020
Statut:
ppublish
Résumé
A 53-year-old woman presented with bone pain and was diagnosed with osteomalacia because of hypophosphatemia, hyperphosphatasemia, bone pain, and radiographic findings. Because her intact-fibroblast growth factor 23 (FGF23) levels were high and contrast-enhanced computed tomography revealed a mass in the anterior ethmoid sinus, FGF23-related osteomalacia was diagnosed. The tumor was resected, but she developed hypercalcemia and elevated blood parathyroid hormone (PTH) levels. Primary hyperparathyroidism (PHPT) was diagnosed, and surgical resection was performed. To our knowledge, this is the first case of a FGF23-producing tumor complicated by PHPT. Because PHPT manifested after resecting the FGF23-producing tumor, FGF23 is thus considered to suppress PTH secretion in humans.
Identifiants
pubmed: 32641663
doi: 10.2169/internalmedicine.4412-19
pmc: PMC7662040
doi:
Substances chimiques
FGF23 protein, human
0
Parathyroid Hormone
0
Fibroblast Growth Factors
62031-54-3
Fibroblast Growth Factor-23
7Q7P4S7RRE
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2523-2527Références
Pathology. 2014 Feb;46(2):95-104
pubmed: 24378391
J Bone Miner Res. 2004 Mar;19(3):429-35
pubmed: 15040831
J Clin Invest. 2007 Dec;117(12):4003-8
pubmed: 17992255
Bone. 2008 Jun;42(6):1235-9
pubmed: 18396126
Clin J Am Soc Nephrol. 2008 May;3(3):658-64
pubmed: 18256372
J Am Coll Surg. 2002 Feb;194(2):126-30
pubmed: 11848628
J Biol Chem. 2005 Jan 28;280(4):2543-9
pubmed: 15531762
J Bone Miner Res. 2007 Jun;22(6):931-7
pubmed: 17352646
J Clin Endocrinol Metab. 2004 Sep;89(9):4489-92
pubmed: 15356053